To provide the information your oncologist is not telling you or doesn't have the time to!
As a medical oncologist, my primary goal is to offer the best possible care to each of my patients. In my practice, I’ve observed how crucial second opinions are in the cancer treatment journey. They provide not just additional insights into treatment options but also peace of mind for patients and their families. This understanding …
Turning the Tide Against Platinum-Resistant Ovarian Cancer In the ever-evolving landscape of cancer treatment, ovarian cancer remains one of the most challenging battles. Platinum-resistant ovarian cancer, in particular, presents a formidable foe, often leaving patients and healthcare providers grappling with limited treatment options. But amidst this struggle, a beacon of hope emerges with the advent …
Unveiling a New Era in Colorectal Cancer Treatment: The Promise of KRAS G12C Inhibition Colorectal cancer stands as one of the most common and deadly forms of cancer worldwide. Despite advances in treatment, the search for more effective and targeted therapies continues. A significant breakthrough in this quest is the understanding and targeting of specific …
In the ongoing battle against cervical cancer, a ray of hope emerges with the FDA’s recent approval of a groundbreaking treatment approach. For women grappling with advanced stages of this disease, this marks a significant advancement, offering new possibilities in their treatment journey. Understanding Cervical Cancer: Cervical cancer, a malignancy arising in the cervix, presents …
In medicine, biases, whether implicit or explicit, can significantly impact patient care. These biases might manifest as preconceived notions or preferences that subtly influence treatment recommendations. In the case of a patient of mines with metastatic GIST who developed acute renal failure secondary to an obstructing pelvis mass, a consulting urologist on call suggested to …
New data published in NEJM may new treatment options for patients dealing with metastatic small cell carcinoma! Small-cell lung cancer (SCLC) stands as one of the most aggressive forms of cancer, often leaving patients and their families grappling with limited treatment options and a prognosis that can seem disheartening. But amidst these challenges, there emerges …
I recently took a trip with my family for about two weeks. It is always a bit nerve wracking to take off for some personal time given that there are so many moving parts in any given day. I wrote this post to remind patients and their families that no matter where your oncologist may …
If you or a loved one is battling locally advanced or metastatic urothelial cancer (la/mUC), there’s groundbreaking news to share. On December 15, 2023, the Food and Drug Administration (FDA) gave the green light to a dynamic combination of treatments: enfortumab vedotin-ejfv (Padcev) and pembrolizumab (Keytruda). This approval is especially significant for patients ineligible for …
On December 14, 2023, the FDA gave the green light to belzutifan (Welireg, Merck & Co., Inc.), offering new hope for individuals battling advanced kidney cancer. It’s like unlocking a powerful tool after trying different strategies. Understanding Belzutifan’s Power Against Kidney Cancer Imagine your body as a bustling city with the kidneys playing the role …
Amongst my medical oncology colleagues, we each do about two months a year rounding with the inpatient team of fellows, residents, students, pharmacists, and extenders for either the inpatient medical oncology or hematology service. So any cancer patient admitted to our hospital system will often be seen by these two teams. In addition, I often …